{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T21:55:49Z","timestamp":1781474149063,"version":"3.54.1"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Myotonic dystrophy (DM), the most common adult-onset muscular dystrophy, affects not only motor function and muscle integrity but also leads to debilitating cardiopulmonary, gastrointestinal, and multisystem complications. Central nervous system (CNS) involvement is increasingly recognized, manifesting as impairments in working memory, executive function, sleep regulation, and mood and behavior. These interrelated, multisystemic features contribute to multifaceted symptoms that significantly reduce quality of life for patients and their families. To identify potential biomarkers of CNS disease activity in DM1, we performed the first exploratory cerebrospinal fluid (CSF) proteomic profiling study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      CSF samples from patients with DM1 (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f= 11) and healthy controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f= 5) were analyzed using Olink monoclonal antibody panels, quantifying 1,072 proteins. LASSO (Least Absolute Shrinkage and Selection Operator) regression identified proteins discriminating between DM1 and controls. Pathway enrichment analysis was performed using the Reactome database to assess biological significance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six candidate biomarker proteins were differentially expressed between between DM1 patients and controls: CKAP4, SCARF1, NCAM1, CD59, PTH1R, and CA4. LASSO analysis further identified 15 proteins discriminating DM1 and controls, implicating pathways related to neuronal health, neuroinflammation, cognitive impairment, skeletal abnormalities, motor control, neuromuscular junction integrity, and cytoskeletal regulation. Dysregulated pathways included IGF transport, MAPK signaling, NCAM signaling, and broader signal transduction cascades pathways also implicated in other neurodevelopmental, neurodegenerative, and neuromuscular disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This first exploratory CSF proteomic analysis in DM1 identified dysregulated protein networks that may underlie CNS dysfunction in this multisystemic disease. These findings provide novel insights into DM1 pathophysiology and support the potential of CSF proteomic signatures as candidate diagnostic tools, indicators of disease activity, and measures of therapeutic response, pending validation in larger, independent cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnins.2025.1709678","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:34:42Z","timestamp":1764138882000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Cerebrospinal fluid proteomic profiling reveals potential biomarkers and altered pathways in myotonic dystrophy type 1"],"prefix":"10.3389","volume":"19","author":[{"given":"Marwa","family":"Zafarullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine A.","family":"Hagerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ghiglieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinda B.","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"105090","DOI":"10.1016\/j.phrs.2020.105090","article-title":"Map kinase signaling as therapeutic target for neurodegeneration","volume":"160","author":"Ahmed","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0960-8966(97)00144-2","article-title":"Impaired cerebral glucose metabolism in myotonic dystrophy: a triplet-size dependent phenomenon","volume":"8","author":"Annane","year":"1998","journal-title":"Neuromuscul. Disord."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JND-221645","article-title":"Towards the identification of biomarkers for muscle function improvement in myotonic dystrophy type 1","volume":"10","author":"Aoussim","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"570586","DOI":"10.3389\/fnmol.2020.570586","article-title":"Functions of p38 MAP kinases in the central nervous system","volume":"13","author":"Asih","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"E9376","DOI":"10.1073\/pnas.1707108114","article-title":"\u03b2-III-spectrin spinocerebellar ataxia type 5 mutation reveals a dominant cytoskeletal mechanism that underlies dendritic arborization","volume":"114","author":"Avery","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e64159","DOI":"10.7554\/eLife.64159","article-title":"Cerebrospinal fluid proteome maps detect pathogen-specific host response patterns in meningitis","volume":"10","author":"Bakochi","year":"2021","journal-title":"eLife"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/cm.21282","article-title":"Actin dynamics and cofilin-actin rods in Alzheimer disease","volume":"73","author":"Bamburg","year":"2016","journal-title":"Cytoskeleton"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1093\/brain\/awy231","article-title":"Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial","volume":"141","author":"Bassez","year":"2018","journal-title":"Brain"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.3390\/jcm12206696","article-title":"Cerebrospinal fluid proteomic changes after Nusinersen in patients with spinal muscular atrophy","volume":"12","author":"Beaudin","year":"2023","journal-title":"J. Clin. Med."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B Stat Methodol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jcsm.12178","article-title":"Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue","volume":"8","author":"Boengler","year":"2017","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"955753","DOI":"10.3389\/fmolb.2022.955753","article-title":"Transcriptome changes in DM1 patients\u2019 tissues are governed by the RNA interference pathway","volume":"9","author":"Braun","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e149915","DOI":"10.1172\/jci.insight.149915","article-title":"p38 MAPKs \u2014 roles in skeletal muscle physiology, disease mechanisms, and as potential therapeutic targets","volume":"6","author":"Brennan","year":"2021","journal-title":"JCI Insight"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/nrd2999","article-title":"Targeting protein kinases in central nervous system disorders","volume":"8","author":"Chico","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41582-020-0400-0","article-title":"Complement in neurological disorders and emerging complement-targeted therapeutics","volume":"16","author":"Dalakas","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13195-022-01113-5","article-title":"Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome","volume":"14","author":"Dammer","year":"2022","journal-title":"Alzheimer's Res Ther"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11910-005-0024-1","article-title":"Genetics and molecular pathogenesis of the myotonic dystrophies","volume":"5","author":"Day","year":"2005","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fnana.2018.00113","article-title":"Advances in Parkinson\u2019s disease: 200 years later","volume":"12","author":"Del Rey","year":"2018","journal-title":"Front. Neuroanat."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"7000","DOI":"10.1007\/s00415-024-12670-0","article-title":"Thrombospondin-4 as potential cerebrospinal fluid biomarker for therapy response in pediatric spinal muscular atrophy","volume":"271","author":"Dobelmann","year":"2024","journal-title":"J. Neurol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.37349\/ent.2022.00030","article-title":"Blockage of thrombospondin 4 secreted by spinal astrocytes may be a promising therapeutic target in the treatment of neuropathic pain","author":"D\u00fczenli","year":"2022","journal-title":"Explor. Neuroprotective Ther."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.3390\/ijms21165624","article-title":"Involvement of p38 MAPK in synaptic function and dysfunction","volume":"21","author":"Falcicchia","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.3390\/cells10081930","article-title":"Neuroinflammation and Alzheimer\u2019s disease: a machine learning approach to CSF proteomics","volume":"10","author":"Gaetani","year":"2021","journal-title":"Cells"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"110017","DOI":"10.1016\/j.biopha.2020.110017","article-title":"Src-family protein tyrosine kinases: a promising target for treating chronic pain","volume":"125","author":"Ge","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"662035","DOI":"10.3389\/fncel.2021.662035","article-title":"Integrative cell type-specific multi-omics approaches reveal impaired programs of glial cell differentiation in mouse culture models of DM1","volume":"15","author":"Gonz\u00e1lez-Barriga","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"7446","DOI":"10.1038\/s41380-021-01236-5","article-title":"Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorder","volume":"26","author":"G\u00f6teson","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3233\/JND-200558","article-title":"Dysregulation of GSK3\u03b2-target proteins in skin fibroblasts of myotonic dystrophy type 1 (DM1) patients","volume":"8","author":"Grande","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"ref27","first-page":"1164","article-title":"Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy","volume":"52","author":"Harley","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/brain\/aws367","article-title":"Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour","volume":"136","author":"Hern\u00e1ndez-Hern\u00e1ndez","year":"2013","journal-title":"Brain"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1038\/sj.emboj.7600300","article-title":"Muscleblind proteins regulate alternative splicing","volume":"23","author":"Ho","year":"2004","journal-title":"EMBO J."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"12952","DOI":"10.1073\/pnas.1912839117","article-title":"Inflammation-related plasma and CSF biomarkers for multiple sclerosis","volume":"117","author":"Huang","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/jmg.29.11.774","article-title":"The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy","volume":"29","author":"Hunter","year":"1992","journal-title":"J. Med. Genet."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"4262","DOI":"10.1038\/s41467-019-12282-7","article-title":"Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy","volume":"10","author":"Iida","year":"2019","journal-title":"Nat. Commun."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"4568","DOI":"10.1038\/s41380-022-01724-2","article-title":"Cerebrospinal fluid proteomic study of two bipolar disorder cohorts","volume":"27","author":"Isgren","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1093\/brain\/awac055","article-title":"NCAM1 and GDF15 are biomarkers of Charcot-Marie-tooth disease in patients and mice","volume":"145","author":"Jennings","year":"2022","journal-title":"Brain"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011425","article-title":"Population-based prevalence of myotonic dystrophy type 1 using genetic analysis of statewide blood screening program","volume":"96","author":"Johnson","year":"2021","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA)"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1464-5491.2005.01432.x","article-title":"Low-dose metformin improves hyperglycaemia related to myotonic dystrophy","volume":"22","author":"Kouki","year":"2005","journal-title":"Diabet. Med."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1083\/jcb.120.4.1059","article-title":"Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family","volume":"120","author":"Lawler","year":"1993","journal-title":"J. Cell Biol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.3390\/biomedicines11082265","article-title":"Characterization of the Ang\/Tie2 Signaling pathway in the diaphragm muscle of DMD mice","volume":"11","author":"Lin","year":"2023","journal-title":"Biomedicine"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e1134","DOI":"10.1371\/journal.pone.0001134","article-title":"Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action","volume":"2","author":"Llagostera","year":"2007","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"10650","DOI":"10.3390\/ijms241310650","article-title":"Therapeutic targeting of the GSK3\u03b2-CUGBP1 pathway in myotonic dystrophy","volume":"24","author":"Lutz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1126\/science.289.5485.1769","article-title":"Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat","volume":"289","author":"Mankodi","year":"2000","journal-title":"Science"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.1093\/hmg\/dds185","article-title":"Somatic instability of the expanded CTG triplet repeat in myotonic dystrophy type 1 is a heritable quantitative trait and modifier of disease severity","volume":"21","author":"Morales","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3390\/cells9020358","article-title":"Much more than a scaffold: cytoskeletal proteins in neurological disorders","volume":"9","author":"Mu\u00f1oz-Lasso","year":"2020","journal-title":"Cells"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1007\/s00415-023-11633-1","article-title":"Periostin as a blood biomarker of muscle cell fibrosis, cardiomyopathy and disease severity in myotonic dystrophy type 1","volume":"270","author":"Nguyen","year":"2023","journal-title":"J. Neurol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2174\/1570159X18666200814180218","article-title":"Src family kinases in the central nervous system: their emerging role in pathophysiology of migraine and neuropathic pain","volume":"19","author":"Nie","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3389\/fneur.2019.01229","article-title":"Insulin signaling as a key moderator in myotonic dystrophy type 1","volume":"10","author":"Nieuwenhuis","year":"2019","journal-title":"Front. Neurol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s43856-023-00256-2","article-title":"Nusinersen mitigates neuroinflammation in severe spinal muscular atrophy patients","volume":"3","author":"Nuzzo","year":"2023","journal-title":"Commun. Med."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cortex.2017.08.008","article-title":"The cognitive profile of myotonic dystrophy type 1: a systematic review and meta-analysis","volume":"95","author":"Okkersen","year":"2017","journal-title":"Cortex"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"4288","DOI":"10.1093\/hmg\/ddw260","article-title":"Frataxin silencing alters microtubule stability in motor neurons: implications for Friedreich\u2019s ataxia","volume":"25","author":"Piermarini","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67769-1","article-title":"Targeted proteomics of cerebrospinal fluid in treatment na\u00efve multiple sclerosis patients identifies immune biomarkers of clinical phenotypes","volume":"14","author":"Rabin","year":"2024","journal-title":"Sci. Rep."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/ni.2670","article-title":"The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity","volume":"14","author":"Ramirez-Ortiz","year":"2013","journal-title":"Nat. Immunol."},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1001\/jama.1993.03500150072029","article-title":"Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring","volume":"269","author":"Redman","year":"1993","journal-title":"JAMA"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"105330","DOI":"10.1016\/j.neubiorev.2023.105330","article-title":"The role of insulin\/IGF1 signalling in neurodevelopmental and neuropsychiatric disorders \u2013 evidence from human neuronal cell models","volume":"153","author":"R\u00e9thelyi","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1016\/j.celrep.2017.06.006","article-title":"Downregulation of the glial GLT1 glutamate transporter and Purkinje cell dysfunction in a mouse model of myotonic dystrophy","volume":"19","author":"Sicot","year":"2017","journal-title":"Cell Rep."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"100683","DOI":"10.1016\/j.mcpro.2023.100683","article-title":"Integrative Proteogenomics for differential expression and splicing variation in a DM1 mouse model","volume":"23","author":"Solovyeva","year":"2024","journal-title":"Mol. Cell. Proteomics"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"155134","DOI":"10.1016\/j.cyto.2020.155134","article-title":"Interleukin-6: a neuro-active cytokine contributing to cognitive impairment in Duchenne muscular dystrophy?","volume":"133","author":"Stephenson","year":"2020","journal-title":"Cytokine"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1016\/j.nmd.2023.07.267","article-title":"O15 large-scale proteomics profiling of peripheral blood of DM1 patients identifies biomarkers for disease severity and physical activity","volume":"33","author":"'t Hoen","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1590\/s0100-879x2003000500001","article-title":"Protein defects in neuromuscular diseases","volume":"36","author":"Vainzof","year":"2003","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1101\/2025.09.05.25335077","article-title":"Large-scale proteomics profiling of peripheral blood of DM1 patients identifies biomarkers for disease severity and functional capacity","author":"Van As","year":"2025","journal-title":"Neurology"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1093\/hmg\/ddq277","article-title":"CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1","volume":"19","author":"Ward","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"101628","DOI":"10.1016\/j.tranon.2023.101628","article-title":"CKAP4-mediated activation of FOXM1 via phosphorylation pathways regulates malignant behavior of glioblastoma cells","volume":"29","author":"Xu","year":"2023","journal-title":"Transl. Oncol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fnins.2020.00045","article-title":"Src inhibition attenuates neuroinflammation and protects dopaminergic neurons in Parkinson\u2019s disease models","volume":"14","author":"Yang","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bbr.2018.11.012","article-title":"The association between NCAM1 levels and behavioral phenotypes in children with autism spectrum disorder","volume":"359","author":"Yang","year":"2019","journal-title":"Behav. Brain Res."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40035-015-0030-4","article-title":"Posttranslational modifications of \u03b1-tubulin in Alzheimer disease","volume":"4","author":"Zhang","year":"2015","journal-title":"Transl. Neurodegener."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1709678\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:34:43Z","timestamp":1764138883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1709678\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":66,"alternative-id":["10.3389\/fnins.2025.1709678"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2025.1709678","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"article-number":"1709678"}}